Presented by Mölnlycke Post Acute
Speaker:
Thomas E. Serena, MD, FACS
CEO/Medical Director, SerenaGroup®
President, Association for Advancement of Wound Care
Director, SerenaGroup Research Foundation
Objectives:
- Describe the mechanism of action of the novel Mepilex® Border Flex dressing.
- Choose the appropriate patients for this novel technology.
- Consider participating in further studies with the Mepilex® Border Flex dressing.